Clinical Trial Update: A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for VVN461 ophthalmic solution in non-infectious anterior uveitis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Anterior Uveitis

Drugs mentioned

• VVN461

Snippet

Sponsor: VivaVision Biotech, Inc | Conditions: Non-infectious Anterior Uveitis | Phase 3 | Status: NOT_YET_RECRUITING